Novo Nordisk's GLP-1 receptor agonist semaglutide has shown efficacy as a treatment for metabolic dysfunction-associated steatohepatitis (MASH) in a phase 3 trial, potentially teeing up US and ...
Boehringer Ingelheim’s weight-loss drug candidate survodutide could also be effective for liver disease metabolic dysfunction-associated steatohepatitis (MASH), if the results of a mid-stage trial are ...
UP is trading near the bottom of its 52-week range and below its 200-day simple moving average. Price change The price of UP shares has decreased $0.30 since the market last closed. This is a 5.24% ...
NPR's Up First is the news you need to start your day. The three biggest stories of the day, with reporting and analysis from NPR News — in 10 minutes. Available weekdays at 6:30 a.m. ET, with hosts ...
The best time to put your money in a savings account is when interest rates are increasing. A bump-up CD can help you take advantage of such an environment and maximize your yields. A bump-up CD is a ...
Yarilet Perez is an experienced multimedia journalist and fact-checker with a Master of Science in Journalism. She has worked in multiple cities covering breaking news, politics, education, and more.
Some of the best growth stocks aren't household names, at least not yet. These up-and-coming companies are still relatively early in their growth cycle. Investors could earn enormous returns as they ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results